Identical embryonal proteins in intact and isolated tissues of maize (Zea mays L.).

Planta

Siberian Institute of Plant Physiology and Biochemistry, Siberian Branch, Academy of Sciences of USSR, P.O. Box 1243, 664033, Irkutsk 33, USSR.

Published: January 1979

Minor antigens characteristic of developing and mature embryos were not found in the shoot and root meristems of the seedlings. Some of these embryonal antigens (EA) were present, however, in callus and cell-suspension cultures, irrespective of their tissue origin, and were maintained throughout repeated subcultures, in some cases for more than 2 years. These EA were distinct both from the meristematic antigens found in the intact seedlings and in callus cultures, and from organ-specific antigens found only in intact plants. The EA of callus tissues derived from several maize genotypes were serologically identical. We therefore assume that these EA are "proliferation proteins" or "early proteins" expressed by cells that have not undergone any determination and lack any tissue or organ specificity.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF00454448DOI Listing

Publication Analysis

Top Keywords

antigens intact
8
identical embryonal
4
embryonal proteins
4
proteins intact
4
intact isolated
4
isolated tissues
4
tissues maize
4
maize zea
4
zea mays
4
mays minor
4

Similar Publications

Quantitative site-specific N-glycosylation analysis reveals IgG glyco-signatures for pancreatic cancer diagnosis.

Clin Proteomics

December 2024

Department of Pancreatic Surgery and Institutes for Systems Genetics, West China Hospital, Sichuan University, Keyuan 4th Road, Gaopeng Avenue, Hi-tech Zone, Chengdu, Sichuan, 610041, China.

Background: Pancreatic cancer is a highly aggressive tumor with a poor prognosis due to a low early detection rate and a lack of biomarkers. Most of pancreatic cancer is pancreatic ductal adenocarcinoma (PDAC). Alterations in the N-glycosylation of plasma immunoglobulin G (IgG) have been shown to be closely associated with the onset and development of several cancers and could be used as biomarkers for diagnosis.

View Article and Find Full Text PDF

[B cells in chronic hepatitis: advances and mechanistic].

Zhonghua Gan Zang Bing Za Zhi

December 2024

Senior Department of Infection Disease, the Fifth Medical Center of PLA General Hospital, Beijing100039, China.

The article reviews the role and functional diversity of B cells in chronic hepatitis B (CHB). B cells play a crucial role in humoral immunity, participating in the clearance of hepatitis B virus (HBV) through antibody production, antigen presentation, and immune regulation. In HBV infection, B cells exhibit antigenic heterogeneity, with immune responses to different HBV antigens varying.

View Article and Find Full Text PDF

Background: Loss-of-function mutations of (, also termed as ()) are frequently detected in patients with non-small cell lung cancer (NSCLC). The mutant NSCLC was refractory to almost all the antitumor treatments, including programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) blockade therapy. Unfortunately, mechanisms underlying resistance to immunotherapy are not fully understood.

View Article and Find Full Text PDF

Conventional T cell-directed immunosuppression is the mainstay of standard-of-care therapy to prevent graft rejection in clinical organ transplantation. However, it remains ineffective in preventing experimental and clinical organ xenograft rejection. Here, we explored the impact of allogeneic versus xenogeneic antigen stimulation on human T cell responses and gene profile.

View Article and Find Full Text PDF

Excess shed mesothelin disrupts pancreatic cancer cell clustering to impair peritoneal colonization.

FASEB J

December 2024

Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Peritoneum is the second most common site of metastasis in patients with pancreatic ductal adenocarcinoma (PDAC). Peritoneal colonization is impaired in PDAC cells with knockout (KO) of the cancer surface antigen mesothelin (MSLN) or by introducing Y318A mutation in MSLN to prevent binding to mucin-16 (MUC-16). MSLN has a membrane-bound form but is also shed to release soluble MSLN (sMSLN).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!